Springer Nature AG & Co KGaA (SPG) fair value: what the stock is really worth
As of Nov 10, 2026: fair value (intrinsic value) of Springer Nature AG & Co KGaA stock €31.42, price €22.10, upside +42.2%, quality 75 out of 100. Rating: undervalued. Calculated from audited financials with 23 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.
How to read this chart
25‑month range €14.29 – €26.07 · fair‑value band €22.47 – €40.73 · the €22.10 price screens below the €31.42 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.
Follow Springer Nature AG & Co KGaA in your weekly email
Every Wednesday you see whether Springer Nature AG & Co KGaA is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Springer Nature AG & Co. KGaA, together with its subsidiaries, engages in the publishing business in Germany, the United Kingdom, the United States, and internationally. The company operates through three segments: Research, Education, and Health.
Show moreShow less
It offers journals across various academic disciplines under the Nature Portfolio and Springer brand names; books in print and digital formats across various scientific disciplines, including monographs, textbooks, conference proceedings, handbook series, reference works, and briefs under the Springer and Palgrave Macmillan brand names; and support services to researchers, institutions, and industry professionals with AI-powered tools and services, such as AdisInsight, Springer Nature Experiments, protocols.io, and SpringerMaterials, as well as professional development and career services under the Nature Masterclasses, Nature Careers, and Nature Conferences brand names.
The company also provides English language teaching content and national curricula learning resources under the Macmillan Education brand name.
In addition, it offers specialist information and services to healthcare professionals under the Springer Medizin brand name; publications, learning solutions, and professional services to healthcare practitioners and students under the BSL brand name; content and services related to drug treatments, medical devices, and diagnostics under the Springer Health+ brand name; and Cureus Journal of Medical Science, a peer-reviewed OA medical journal.
The company was founded in 1842 and is based in Berlin, Germany. Springer Nature AG & Co. KGaA operates as a subsidiary of GvH Vermögensverwaltungsgesellschaft Xxxiii mbH.
Stock analysis
Springer Nature AG & Co KGaA (SPG) currently trades at €22.10, while our model-based Fair Value estimate is €31.42, implying the stock looks roughly 30% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of €34.97 per share, and 17 of the 23 models we run sit above the €22.10 price.
Bear case: the Earnings-Based group reads lowest at €13.54, and 6 of the 23 models stay below the price. Data coverage for this calculation is high.
Scenario range: €22.47 (bear) to €40.73 (bull), the price of €22.10 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 75/100 (high quality), in the Communication Services sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Springer Nature AG & Co KGaA reported revenue of €1.9B in FY2025 versus €1.9B in FY2023, a compound +2.0%/yr. Reported net income was €356M in FY2025, compounding +379.0%/yr from FY2023.
Key figures
Market cap €4.4B Mid · P/E ratio 13.4 · P/S ratio 2.25 · EPS (TTM) €1.65 · Dividend yield 3.8% · Net margin 16.8% · Return on equity 17.1% · Return on assets (EBIT) 8.1% (3-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 70 out of 100 (medium confidence).
What moves the price
The share trades at its 52-week high and 55% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Communication Services peers we cover trades at −6% fair-value upside, at 42%, SPG screens cheaper than that median.
Fair Value models
Bear€22.47Fair Value €31.42Bull€40.73
Price €22.10 · Upside +42.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (€0.7077 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.77/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 2 usable fiscal years, at least 4 required
not computed
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−2.4%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+4.1%
Yearly sales growth analysts expect, extended to five years.
After inflation (euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about −4.4% a year for the price and +1.8% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (9 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.
AI conclusion: High margins and solid ROE point to pricing strength in publishing, yet other moat areas lack clear public signals and multiple data gaps persist.
Main risk: Open access shifts could squeeze the high-margin recurring revenue that anchors the publishing business model.
Springer Nature is partnering with Google DeepMind to develop an AI assistant that helps peer reviewers navigate complex manuscripts and focus on specialist judgment. The move addresses surging submission volumes, including AI-generated content, while stressing that human expertise stays at the core. Our models currently see it as undervalued. Will this strengthen the trusted publishing model or risk diluting editorial standards?
Compare Springer Nature AG & Co KGaA with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Publishing · 107 stocks
Beats the industry median on 11/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score75 · Top 25%
Fair Value upside+42.2% · Above median
Profitability
Return on equity (12 months)17.1% · Top 25%
Return on assets7.1% · Top 25%
Net margin (12 months)16.8% · Top 25%
Operating margin (12 months)20.1% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)3.0% · Above median
Dividend yield (12 months)3.8% · Above median
Balance sheet
Debt / equity0.70× · Highest 25%
Valuation Multiplesvs Publishing median · lower = cheaper
P/E (12 months)13.4× · Cheaper than median
P/B2.17× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months)2.25× · Priciest 25%
Price / free cash flow (fiscal year)8.5× · Cheaper than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Springer Nature AG & Co KGaA Fair Value". https://www.fairvalue-calculator.com/stock/SPG.XETRA
Frequently asked questions
Is Springer Nature AG & Co KGaA (SPG) overvalued or undervalued?
As of Nov 10, 2026, our model estimates a fair value of €31.42 versus a price of €22.10, about +42% upside (undervalued).
What is the fair value of SPG?
Our model-based fair value for Springer Nature AG & Co KGaA is €31.42 (as of Nov 10, 2026), built from audited fundamentals. The current price: €22.10.
What is the quality score of SPG?
Springer Nature AG & Co KGaA has a Quality Score of 75/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Springer Nature AG & Co KGaA (SPG)?
Our model-based price target is the fair value of €31.42 (as of Nov 10, 2026) from 23 valuation models. Cautious scenario €22.47, optimistic scenario €40.73. It is a calculation from audited fundamentals, not an analyst target.
What is the Springer Nature AG & Co KGaA stock forecast for 2026?
Our models put fair value at €31.42, about +42% upside versus a price of €22.10 (undervalued). Cautious scenario €22.47, optimistic scenario €40.73. The calculation is refreshed regularly with new filings.
What is the revenue of Springer Nature AG & Co KGaA (SPG)?
Springer Nature AG & Co KGaA reported trailing-twelve-month revenue of about €2.0B (latest available figure, as of Nov 10, 2026).
Does Springer Nature AG & Co KGaA pay a dividend?
Springer Nature AG & Co KGaA currently shows a dividend yield of 3.76% relative to its recent price (as of Nov 10, 2026).
How much is the dividend of Springer Nature AG & Co KGaA (SPG)?
Springer Nature AG & Co KGaA pays a dividend of €0.83 per share a year, a dividend yield of 3.8%. The payout ratio is 50.3% of earnings. Free cash flow covers the dividend 3.15 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Springer Nature AG & Co KGaA (SPG)?
For today's price to be fair in a discounted-cash-flow model, Springer Nature AG & Co KGaA would have to grow free cash flow by -2.4 % per year for five years (discount rate 9.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 2 years revenue grew +2.0 % per year. As of Nov 10, 2026.
What discount rate (WACC) does the fair value of SPG use?
Our models discount Springer Nature AG & Co KGaA at 9.5 %: a base by market capitalisation (mid), country premium for Germany. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Springer Nature AG & Co KGaA that is -2.4 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.5 %) and the same formula as our fair value.
How much growth has Springer Nature AG & Co KGaA (SPG) delivered so far?
Over the past 2 years revenue at Springer Nature AG & Co KGaA grew +2.0 % a year. The price currently implies free-cash-flow growth of -2.4 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Springer Nature AG & Co KGaA (SPG) growing?
The median revenue growth in the sector is +3.8 % a year. That is the yardstick for the growth priced into Springer Nature AG & Co KGaA (-2.4 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Springer Nature AG & Co KGaA (SPG)?
The free-cash-flow yield on the price is 11.83 %: that much free cash flow Springer Nature AG & Co KGaA produces per unit of market value. When it exceeds the discount rate of our models (9.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Springer Nature AG & Co KGaA (SPG)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Springer Nature AG & Co KGaA it is €31.42 per share (as of Nov 10, 2026), against a price of €22.10. It is the blended result of 23 valuation models in 7 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Growth DCF, Economic Profit, Growth Earnings).
Is Springer Nature AG & Co KGaA stock overvalued or undervalued in 2026?
As of Nov 10, 2026, SPG trades below its calculated fair value: price €22.10, fair value €31.42, a gap of about +42% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SPG?
No. The price is what the market pays today (€22.10); the fair value is what the company's own numbers justify (€31.42). For Springer Nature AG & Co KGaA the two are €9.32 per share apart. That gap is exactly why we show both numbers side by side.
How much is Springer Nature AG & Co KGaA worth?
The market values Springer Nature AG & Co KGaA at about €4.4B (market capitalisation, as of Nov 10, 2026). Per share that is €22.10; our models calculate a fair value of €31.42 per share.
What do the bullish and bearish scenarios say about SPG?
Our models span a range for Springer Nature AG & Co KGaA: cautious scenario €22.47, base €31.42, optimistic €40.73 per share (as of Nov 10, 2026, price €22.10). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of SPG?
Springer Nature AG & Co KGaA trades at a price-to-earnings ratio of 13.4 (as of Nov 10, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €31.42 is built from several models across several years. Other multiples: P/B 2.2, P/S 2.2, EV/EBITDA 7.8.
How solid is the balance sheet of Springer Nature AG & Co KGaA (SPG)?
Balance-sheet figures for Springer Nature AG & Co KGaA (as of Nov 10, 2026): return on equity 17.1%, debt of 0.70 per unit of equity. They feed the Quality Score of 75/100, which measures business quality independently of the share price.
How far is SPG from its 52-week high?
Springer Nature AG & Co KGaA trades at €22.10, at its 52-week high of €22.10 and 55% above the low of €14.29 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of €31.42 is for.
Which stocks are comparable to Springer Nature AG & Co KGaA?
From the same area (Communication Services) we also value The New York Times Company, Xinhua Winshare Publishing and Media Co, Jiangsu Phoenix Publishing & Media Corporation, China Science Publishing & Media Ltd, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Springer Nature AG & Co KGaA stock attractive at the current price?
The data as of Nov 10, 2026: price €22.10, calculated fair value €31.42 (+42%), Quality Score 75/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SPG calculated?
We run Springer Nature AG & Co KGaA through 23 models from 7 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of €31.42 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.2% above its aggregate fair value. Springer Nature AG & Co KGaA currently trades 30% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Springer Nature AG & Co KGaA (SPG)?
The closing price on Nov 10, 2026 was €22.10. Our model-based fair value is €31.42, about +42% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Springer Nature AG & Co KGaA right now?
The rarer combination: high quality (75/100) AND below fair value. That earns a closer look rather than a quick verdict. A fairly wide model range (€22.47 to €40.73) leaves room in how you read the outcome.
Key figures of Springer Nature AG & Co KGaA
How large is the market capitalisation of Springer Nature AG & Co KGaA (SPG)?
The market capitalisation of Springer Nature AG & Co KGaA is €4.4B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Springer Nature AG & Co KGaA (SPG)?
The price-to-sales ratio of Springer Nature AG & Co KGaA is 2.25 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Springer Nature AG & Co KGaA (SPG)?
Earnings per share at Springer Nature AG & Co KGaA are €1.65 (price ÷ EPS = P/E 13.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Springer Nature AG & Co KGaA (SPG)?
The dividend yield of Springer Nature AG & Co KGaA is 3.8% (payout 50.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Springer Nature AG & Co KGaA (SPG)?
The net margin of Springer Nature AG & Co KGaA is 16.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Springer Nature AG & Co KGaA (SPG)?
The return on equity (ROE) of Springer Nature AG & Co KGaA is 17.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Springer Nature AG & Co KGaA (SPG)?
On an EBIT basis the return on assets of Springer Nature AG & Co KGaA is 8.1% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Springer Nature AG & Co KGaA (SPG)?
The operating margin of Springer Nature AG & Co KGaA is 20.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Springer Nature AG & Co KGaA (SPG)?
Revenue at Springer Nature AG & Co KGaA is growing +3.0% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Springer Nature AG & Co KGaA (SPG)?
Earnings per share at Springer Nature AG & Co KGaA are growing −21.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Springer Nature AG & Co KGaA (SPG) carry?
The net debt of Springer Nature AG & Co KGaA is €1.2B (fiscal year 2025, ≈ 2.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Springer Nature AG & Co KGaA in the live analysis
One click puts Springer Nature AG & Co KGaA on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 10, 2026